首页 > 最新文献

Cirugia Cardiovascular最新文献

英文 中文
Credits 学分
IF 0.3 Q4 SURGERY Pub Date : 2025-11-01 DOI: 10.1016/S1134-0096(25)00258-X
{"title":"Credits","authors":"","doi":"10.1016/S1134-0096(25)00258-X","DOIUrl":"10.1016/S1134-0096(25)00258-X","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 6","pages":"Page i"},"PeriodicalIF":0.3,"publicationDate":"2025-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145435346","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cirugía del anillo vascular: ¿cuándo intervenir? Revisión de nuestra casuística y presentación de un algoritmo de manejo 血管环手术:何时介入?回顾我们的案例并介绍管理算法。
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.06.006
Carlos Nieto-Moral, Enrique García-Torres, Francisco Javier Arias-Dachary, Lorenzo Boni

Introduction and objectives

The term vascular ring encompasses different anatomical variants, the result of anomalous embryonic development of the primitive aortic arches, with the potential to cause injuries to the airway and/or digestive tract. Despite a more frequent, early and/or prenatal diagnosis, there are no clear management recommendations in clinical guidelines.
We present the management algorithm of this center, supported by the literature and a review of the results of patients operated on there.

Methods

Retrospective review of vascular ring interventions at the Hospital Universitario 12 de Octubre in Madrid, between January 2014 and March 2023, and analysis of the literature.

Results

Between January 2014 and March 2023, a total of 31 patients were operated on without any deaths being recorded. In 67.7% of cases the approach was thoracoscopic, and prenatal diagnosis was performed in 82.7% of susceptible cases.

Conclusions

Early surgery is considered to avoid sequelae of this pathology, without significant differences in surgical complications or associated with the type of approach, thoracoscopic or thoracotomy/sternotomy.
They meet the criteria for surgical indication: patients with symptomatic vascular rings when they first appear, asymptomatic complete vascular rings with a decrease in the airway lumen ≥ 50% in dynamic imaging tests, and all elective double aortic arches around 6 months of age, regardless of clinical symptoms and degree of airway compression.
术语血管环包含不同的解剖变异,是原始主动脉弓异常胚胎发育的结果,有可能导致气道和/或消化道损伤。尽管更频繁,早期和/或产前诊断,临床指南中没有明确的管理建议。我们提出了该中心的管理算法,并以文献和对在该中心手术的患者的结果进行了回顾。方法回顾性分析2014年1月至2023年3月12日在马德里大学医院进行的血管环介入治疗,并对文献进行分析。结果2014年1月至2023年3月共手术31例,无死亡病例。67.7%的病例采用胸腔镜入路,82.7%的易感病例行产前诊断。结论早期手术可避免该病理的后遗症,手术并发症无显著差异,且与入路类型、胸腔镜或开胸/开胸术相关。符合手术指征标准:首次出现有症状的血管环,动态影像学检查无症状的完整血管环,气道管腔减少≥50%,6月龄左右均为选择性双主动脉弓,无论临床症状和气道受压程度如何。
{"title":"Cirugía del anillo vascular: ¿cuándo intervenir? Revisión de nuestra casuística y presentación de un algoritmo de manejo","authors":"Carlos Nieto-Moral,&nbsp;Enrique García-Torres,&nbsp;Francisco Javier Arias-Dachary,&nbsp;Lorenzo Boni","doi":"10.1016/j.circv.2024.06.006","DOIUrl":"10.1016/j.circv.2024.06.006","url":null,"abstract":"<div><h3>Introduction and objectives</h3><div>The term vascular ring encompasses different anatomical variants, the result of anomalous embryonic development of the primitive aortic arches, with the potential to cause injuries to the airway and/or digestive tract. Despite a more frequent, early and/or prenatal diagnosis, there are no clear management recommendations in clinical guidelines.</div><div>We present the management algorithm of this center, supported by the literature and a review of the results of patients operated on there.</div></div><div><h3>Methods</h3><div>Retrospective review of vascular ring interventions at the Hospital Universitario 12 de Octubre in Madrid, between January 2014 and March 2023, and analysis of the literature.</div></div><div><h3>Results</h3><div>Between January 2014 and March 2023, a total of 31 patients were operated on without any deaths being recorded. In 67.7% of cases the approach was thoracoscopic, and prenatal diagnosis was performed in 82.7% of susceptible cases.</div></div><div><h3>Conclusions</h3><div>Early surgery is considered to avoid sequelae of this pathology, without significant differences in surgical complications or associated with the type of approach, thoracoscopic or thoracotomy/sternotomy.</div><div>They meet the criteria for surgical indication: patients with symptomatic vascular rings when they first appear, asymptomatic complete vascular rings with a decrease in the airway lumen ≥ 50% in dynamic imaging tests, and all elective double aortic arches around 6 months of age, regardless of clinical symptoms and degree of airway compression.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 244-252"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141848402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
From the neoaortoiliac system to the popliteal artery reconstruction using bovine pericardium grafts 从新髂主动脉系统到用牛心包移植重建腘动脉
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.09.005
Mariana Pinzón-Pinto , Leonardo Randial , Martín Contreras , Juan J. Ramírez-Mosquera , Daniela Arteaga , Luis F. Cabrera-Vargas
{"title":"From the neoaortoiliac system to the popliteal artery reconstruction using bovine pericardium grafts","authors":"Mariana Pinzón-Pinto ,&nbsp;Leonardo Randial ,&nbsp;Martín Contreras ,&nbsp;Juan J. Ramírez-Mosquera ,&nbsp;Daniela Arteaga ,&nbsp;Luis F. Cabrera-Vargas","doi":"10.1016/j.circv.2024.09.005","DOIUrl":"10.1016/j.circv.2024.09.005","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 276-277"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flujometría con doppler pulsado en la evaluación intraoperatoria de los injertos coronarios. ¿Es aún necesaria? 脉冲多普勒血流测量仪在冠状动脉移植物术中评估中的应用:还有必要吗?
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.01.002
Yasser Colao Jimenez
Cardiovascular diseases are the first cause of death worldwide and in Cuba, ischemic heart disease is the most frequent, myocardial revascularization surgery is an established method for its treatment, specifically in coronary multivessel disease. Having a graft quality assessment tool such as Pulsed Doppler Flowmetry is a complement that can be very useful and is also available in our country. To expose the usefulness of the use of pulsed Doppler flowmetry in myocardial revascularization surgery. A non-systematic bibliographic review of the available literature was carried out, in relation to the measurement of coronary flows in the grafts during. A search was carried out from March 1 to April 30, 2023 in the free access search PubMed. The effectiveness of flowmetry was demonstrated by several authors at the time it was created and, although it is currently out of use due to other more effective methods, its applicability in the absence of other tools has contributed to the identification and correction of technical errors in the surgical practice.
心血管疾病是全世界的第一大死亡原因,在古巴,缺血性心脏病是最常见的,心肌血运重建术是治疗该病的既定方法,特别是冠状动脉多血管疾病。有一个移植质量评估工具,如脉冲多普勒血流法是一个非常有用的补充,在我国也是可用的。目的探讨脉冲多普勒血流法在心肌血运重建术中的应用价值。对现有文献进行了非系统的参考文献回顾,涉及在移植过程中冠状动脉血流的测量。从2023年3月1日到4月30日,在PubMed免费检索中进行了搜索。血流法的有效性在其发明之初就得到了几位作者的证明,尽管由于其他更有效的方法,它目前已不再使用,但在缺乏其他工具的情况下,它的适用性有助于识别和纠正手术实践中的技术错误。
{"title":"Flujometría con doppler pulsado en la evaluación intraoperatoria de los injertos coronarios. ¿Es aún necesaria?","authors":"Yasser Colao Jimenez","doi":"10.1016/j.circv.2024.01.002","DOIUrl":"10.1016/j.circv.2024.01.002","url":null,"abstract":"<div><div>Cardiovascular diseases are the first cause of death worldwide and in Cuba, ischemic heart disease is the most frequent, myocardial revascularization surgery is an established method for its treatment, specifically in coronary multivessel disease. Having a graft quality assessment tool such as Pulsed Doppler Flowmetry is a complement that can be very useful and is also available in our country. To expose the usefulness of the use of pulsed Doppler flowmetry in myocardial revascularization surgery. A non-systematic bibliographic review of the available literature was carried out, in relation to the measurement of coronary flows in the grafts during. A search was carried out from March 1 to April 30, 2023 in the free access search PubMed. The effectiveness of flowmetry was demonstrated by several authors at the time it was created and, although it is currently out of use due to other more effective methods, its applicability in the absence of other tools has contributed to the identification and correction of technical errors in the surgical practice.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 253-257"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140463742","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fístula aortoesofágica: una urgencia endovascular 主动脉食管瘘:血管内急症
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.03.007
Eloy Rueda-Gomariz , Inmaculada Ballesteros Yáñez , Aníbal Bermúdez-García , Tomás Daroca-Martínez

Introduction

The aortoesophageal fistula is a rare entity with a poor prognosis. The typical clinical presentation is as described by Chiari: dysphagia/chest pain, sentinel bleeding, and massive hemorrhage. Upper gastrointestinal endoscopy and computed tomography scan are fundamental for diagnosis. As for treatment, it is not clearly established. The aim of this article is to present our experience with a case of aortoesophageal fístula treated through transaxillary Thoracic Endovascular Aortic Repair (TEVAR).

Methods

A 63-year-old male patient with a history of diabetes mellitus, smoker, chronic renal failure, and peripheral vascular disease presented with an episode of hematemesis with associated syncope and melaena. The patient underwent upper gastrointestinal endoscopy and computed tomography with intravenous contrast. After diagnosis, the patient underwent implantation of a Medtronic Valiant Navion stent graft via left transaxillary approach after placement of a Sengstaken-Blakemore catheter.

Results

Endoscopy suggested an aortoesophageal fistula, and computed tomography revealed 2 aneurysms in the descending aorta, one of which was in contact with the esophagus. The patient underwent implantation of a stent graft via transaxillary approach after placement of a Sengstaken-Blakemore tube, with good clinical outcome.

Conclusions

The aortoesophageal fistula is a rare and potentially lethal entity that requires a high diagnostic suspicion and emergency treatment, which is not established. Stent graft implantation is a safe therapeutic option as a bridge to patient stabilization, but definitive treatment must be individualized according to case characteristics and etiology.
摘要主动脉食管瘘是一种少见的疾病,预后较差。典型的临床表现如Chiari所描述的:吞咽困难/胸痛,前哨出血和大出血。上消化道内窥镜检查和计算机断层扫描是诊断的基础。至于治疗,目前还没有明确的规定。本文的目的是介绍我们通过经腋窝胸主动脉血管内修复术(TEVAR)治疗食管主动脉fístula的经验。方法男性,63岁,有糖尿病、吸烟、慢性肾衰竭、周围血管疾病病史,以呕血伴晕厥、黑绀发作为临床表现。患者接受了上消化道内窥镜检查和计算机断层扫描及静脉造影剂。确诊后,患者在置入Sengstaken-Blakemore导管后,经左腋下入路植入美敦力Valiant Navion支架。结果内镜提示主动脉食管瘘,ct示降主动脉2个动脉瘤,其中1个与食管接触。患者在置入Sengstaken-Blakemore管后经腋窝入路行支架植入术,临床效果良好。结论主动脉食管瘘是一种罕见且具有潜在致命性的疾病,需要高度的诊断怀疑和急诊治疗,目前尚不明确。支架植入术是一种安全的治疗选择,作为病人稳定的桥梁,但最终的治疗必须根据病例特征和病因进行个体化。
{"title":"Fístula aortoesofágica: una urgencia endovascular","authors":"Eloy Rueda-Gomariz ,&nbsp;Inmaculada Ballesteros Yáñez ,&nbsp;Aníbal Bermúdez-García ,&nbsp;Tomás Daroca-Martínez","doi":"10.1016/j.circv.2024.03.007","DOIUrl":"10.1016/j.circv.2024.03.007","url":null,"abstract":"<div><h3>Introduction</h3><div>The aortoesophageal fistula is a rare entity with a poor prognosis. The typical clinical presentation is as described by Chiari: dysphagia/chest pain, sentinel bleeding, and massive hemorrhage. Upper gastrointestinal endoscopy and computed tomography scan are fundamental for diagnosis. As for treatment, it is not clearly established. The aim of this article is to present our experience with a case of aortoesophageal fístula treated through transaxillary Thoracic Endovascular Aortic Repair (TEVAR).</div></div><div><h3>Methods</h3><div>A 63-year-old male patient with a history of diabetes mellitus, smoker, chronic renal failure, and peripheral vascular disease presented with an episode of hematemesis with associated syncope and melaena. The patient underwent upper gastrointestinal endoscopy and computed tomography with intravenous contrast. After diagnosis, the patient underwent implantation of a Medtronic Valiant Navion stent graft via left transaxillary approach after placement of a Sengstaken-Blakemore catheter.</div></div><div><h3>Results</h3><div>Endoscopy suggested an aortoesophageal fistula, and computed tomography revealed 2<!--> <!-->aneurysms in the descending aorta, one of which was in contact with the esophagus. The patient underwent implantation of a stent graft via transaxillary approach after placement of a Sengstaken-Blakemore tube, with good clinical outcome.</div></div><div><h3>Conclusions</h3><div>The aortoesophageal fistula is a rare and potentially lethal entity that requires a high diagnostic suspicion and emergency treatment, which is not established. Stent graft implantation is a safe therapeutic option as a bridge to patient stabilization, but definitive treatment must be individualized according to case characteristics and etiology.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 233-236"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141392652","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tratamiento multimodal en la hipertensión pulmonar residual tras tromboendarterectomía pulmonar 肺血栓内膜切除术后残留肺动脉高压的多模式疗法
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.06.003
María Jesús López-Gude , Lorena Coronel , Teresa Velazquez-Martín , Enrique Pérez-de la Sota , Jorge E. Centeno-Rodríguez , Andrea Eixerés-Esteve , Eva Aguilar-Blanco , Juan Meca-Aguirrezabalaga , Pilar Escribano-Subías , Christian Muñoz-Guijosa
Pulmonary thromboendarterectomy surgery is the treatment of choice in chronic thromboembolic pulmonary hypertension. Medical treatment or intervention through pulmonary angioplasty should be considered in inoperable patients or with residual pulmonary hypertension after surgery.

Objectives

Communicate the current results of the surgical series. Describe the long-term evolution based on the persistence of pulmonary hypertension.

Material and methods

Until December 2023 we have performed 405 procedures. Right heart catheterization was obtained in 301 patients at 6 months.

Results

Hospital mortality was 4.5%. In 161 control catheterizations (53%), the mean pulmonary artery pressure was less or equal than 25 mmHg. The cumulative survival in these patients is 99%, 99% and 97% at 3, 5 and 10 years. In 78 cases (26%) the pressure was between 26 and 34 mmHg. 30% have needed treatment with pulmonary vasodilators and 3% have required pulmonary angioplasty. The cumulative survival is 100%, 95% and 95% at 3, 5 and 10 years. In the rest, the pressure was equal or greater than 35 mmHg. 82% have been treated with pulmonary vasodilators and 21% with pulmonary angioplasties. The cumulative survival is 92%, 90% and 81% at 3, 5 and 10 years with significant difference with the previous groups (Log Rank = 0.02).

Conclusions

Pulmonary endarterectomy surgery is curative in the majority of patients. The multidisciplinary approach and multimodal treatment are essential in complex situations such as residual pulmonary hypertension after surgery, achieving excellent long-term results.
肺血栓动脉内膜切除术是治疗慢性血栓栓塞性肺动脉高压的首选方法。对于不能手术或术后残留肺动脉高压的患者,应考虑药物治疗或肺动脉成形术干预。目的交流手术系列的最新结果。描述肺动脉高压持续存在的长期演变。材料和方法截至2023年12月,我们已完成405例手术。301例患者6个月时行右心导管。结果住院死亡率为4.5%。在161例(53%)对照插管中,平均肺动脉压小于或等于25 mmHg。这些患者在3年、5年和10年的累积生存率分别为99%、99%和97%。78例(26%)血压在26 - 34 mmHg之间。30%的患者需要肺血管扩张剂治疗,3%的患者需要肺血管成形术。3年、5年和10年的累积生存率分别为100%、95%和95%。其余患者血压均大于等于35 mmHg。82%用肺血管扩张剂治疗,21%用肺血管成形术治疗。3年、5年和10年的累积生存率分别为92%、90%和81%,与前3组比较差异有统计学意义(Log Rank = 0.02)。结论肺内膜切除术对绝大多数患者是有效的。在复杂的情况下,如术后残余肺动脉高压,多学科方法和多模式治疗是必不可少的,可以获得良好的长期效果。
{"title":"Tratamiento multimodal en la hipertensión pulmonar residual tras tromboendarterectomía pulmonar","authors":"María Jesús López-Gude ,&nbsp;Lorena Coronel ,&nbsp;Teresa Velazquez-Martín ,&nbsp;Enrique Pérez-de la Sota ,&nbsp;Jorge E. Centeno-Rodríguez ,&nbsp;Andrea Eixerés-Esteve ,&nbsp;Eva Aguilar-Blanco ,&nbsp;Juan Meca-Aguirrezabalaga ,&nbsp;Pilar Escribano-Subías ,&nbsp;Christian Muñoz-Guijosa","doi":"10.1016/j.circv.2024.06.003","DOIUrl":"10.1016/j.circv.2024.06.003","url":null,"abstract":"<div><div>Pulmonary thromboendarterectomy surgery is the treatment of choice in chronic thromboembolic pulmonary hypertension. Medical treatment or intervention through pulmonary angioplasty should be considered in inoperable patients or with residual pulmonary hypertension after surgery.</div></div><div><h3>Objectives</h3><div>Communicate the current results of the surgical series. Describe the long-term evolution based on the persistence of pulmonary hypertension.</div></div><div><h3>Material and methods</h3><div>Until December 2023 we have performed 405 procedures. Right heart catheterization was obtained in 301 patients at 6<!--> <!-->months.</div></div><div><h3>Results</h3><div>Hospital mortality was 4.5%. In 161 control catheterizations (53%), the mean pulmonary artery pressure was less or equal than 25<!--> <!-->mmHg. The cumulative survival in these patients is 99%, 99% and 97% at 3, 5 and 10<!--> <!-->years. In 78 cases (26%) the pressure was between 26 and 34<!--> <!-->mmHg. 30% have needed treatment with pulmonary vasodilators and 3% have required pulmonary angioplasty. The cumulative survival is 100%, 95% and 95% at 3, 5 and 10<!--> <!-->years. In the rest, the pressure was equal or greater than 35<!--> <!-->mmHg. 82% have been treated with pulmonary vasodilators and 21% with pulmonary angioplasties. The cumulative survival is 92%, 90% and 81% at 3, 5 and 10<!--> <!-->years with significant difference with the previous groups (Log Rank<!--> <!-->=<!--> <!-->0.02).</div></div><div><h3>Conclusions</h3><div>Pulmonary endarterectomy surgery is curative in the majority of patients. The multidisciplinary approach and multimodal treatment are essential in complex situations such as residual pulmonary hypertension after surgery, achieving excellent long-term results.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 237-243"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141714037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor glómico de tráquea: caso raro e inusual 喉部气管肿瘤:罕见和不寻常的病例
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.05.004
Gutenberg Navarro-Zambrano , Jorge Pozo-Obando , Rommel Espinoza De Los Monteros-Duche , Francisco Guerra-Egas , Jorge Sifuentes-Miyake , Rosario Ramos-Layedra
{"title":"Tumor glómico de tráquea: caso raro e inusual","authors":"Gutenberg Navarro-Zambrano ,&nbsp;Jorge Pozo-Obando ,&nbsp;Rommel Espinoza De Los Monteros-Duche ,&nbsp;Francisco Guerra-Egas ,&nbsp;Jorge Sifuentes-Miyake ,&nbsp;Rosario Ramos-Layedra","doi":"10.1016/j.circv.2024.05.004","DOIUrl":"10.1016/j.circv.2024.05.004","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 268-272"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061530","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Credits 学分
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/S1134-0096(25)00204-9
{"title":"Credits","authors":"","doi":"10.1016/S1134-0096(25)00204-9","DOIUrl":"10.1016/S1134-0096(25)00204-9","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Page i"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061531","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tetralogía de Fallot: arteria coronaria cruzando el tracto de salida ventricular derecho. Opciones quirúrgicas 法洛四联:冠状动脉穿过右心室出口导管。手术选项
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2024.09.006
Consuelo A. Gotor-Pérez, Félix Serrano-Martínez, Alejandro Vazquez-Sánchez, Juan B. Martínez-León
The existence of an anomalous coronary artery crossing the infundibulum of the right ventricle can make surgical repair difficult, as well as increase morbidity and operative mortality in certain pathologies in which it is necessary to treat stenosis at the level of the right ventricular outflow tract, as in the case of patients with Tetralogy of Fallot. The presence of this anomaly often requires a variation of the surgical strategy to avoid injury to the anomalous coronary artery and its fatal consequences. One surgical option is the implantation of a conduit between the right ventricle and the pulmonary artery, but this procedure has certain disadvantages. In this article we report most of the surgical techniques described in the literature, which attempt to treat this group of patients with good results, avoiding the implantation of an extracardiac conduit. In addition, we include a possible decision scheme, which may help the surgeon in the choice of the most appropriate surgical technique, depending on the anatomical characteristics of the patient.
异常冠状动脉穿过右心室漏斗的存在会使手术修复变得困难,并且在某些病理中,需要治疗右心室流出道水平的狭窄,如法洛四联症患者,会增加发病率和手术死亡率。这种异常的存在通常需要改变手术策略,以避免损伤异常冠状动脉及其致命后果。一种手术选择是在右心室和肺动脉之间植入导管,但这种手术有一定的缺点。在这篇文章中,我们报告了文献中描述的大多数手术技术,这些技术试图治疗这组患者,并取得了良好的效果,避免了心外导管的植入。此外,我们还包括一个可能的决策方案,它可以帮助外科医生根据患者的解剖特征选择最合适的手术技术。
{"title":"Tetralogía de Fallot: arteria coronaria cruzando el tracto de salida ventricular derecho. Opciones quirúrgicas","authors":"Consuelo A. Gotor-Pérez,&nbsp;Félix Serrano-Martínez,&nbsp;Alejandro Vazquez-Sánchez,&nbsp;Juan B. Martínez-León","doi":"10.1016/j.circv.2024.09.006","DOIUrl":"10.1016/j.circv.2024.09.006","url":null,"abstract":"<div><div>The existence of an anomalous coronary artery crossing the infundibulum of the right ventricle can make surgical repair difficult, as well as increase morbidity and operative mortality in certain pathologies in which it is necessary to treat stenosis at the level of the right ventricular outflow tract, as in the case of patients with Tetralogy of Fallot. The presence of this anomaly often requires a variation of the surgical strategy to avoid injury to the anomalous coronary artery and its fatal consequences. One surgical option is the implantation of a conduit between the right ventricle and the pulmonary artery, but this procedure has certain disadvantages. In this article we report most of the surgical techniques described in the literature, which attempt to treat this group of patients with good results, avoiding the implantation of an extracardiac conduit. In addition, we include a possible decision scheme, which may help the surgeon in the choice of the most appropriate surgical technique, depending on the anatomical characteristics of the patient.</div></div>","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 258-267"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061030","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Anomalía coronaria en la cirugía de Fallot: un invitado incómodo 法罗手术中的冠状动脉异常:不方便的客人
IF 0.3 Q4 SURGERY Pub Date : 2025-09-01 DOI: 10.1016/j.circv.2025.07.005
Luz Polo López
{"title":"Anomalía coronaria en la cirugía de Fallot: un invitado incómodo","authors":"Luz Polo López","doi":"10.1016/j.circv.2025.07.005","DOIUrl":"10.1016/j.circv.2025.07.005","url":null,"abstract":"","PeriodicalId":42671,"journal":{"name":"Cirugia Cardiovascular","volume":"32 5","pages":"Pages 231-232"},"PeriodicalIF":0.3,"publicationDate":"2025-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145061532","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cirugia Cardiovascular
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1